77 related articles for article (PubMed ID: 9418160)
1. Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.
Malnati MS; Tambussi G; Clerici E; Polo S; Algeri M; Nardese V; Furci L; Lazzarin A; Lusso P
J Biol Regul Homeost Agents; 1997; 11(1-2):40-2. PubMed ID: 9418160
[TBL] [Abstract][Full Text] [Related]
2. Analysis of serum and plasma beta chemokines in primary HIV infection (PHI).
Malnati MS; Tambussi G; Fischetti L; Algeri M; Veglia F; Capiluppi B; Lazzarin A; Lusso P
J Biol Regul Homeost Agents; 2000; 14(1):75-8. PubMed ID: 10763899
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
Chuenchitra T; Wasi C; de Souza M; Nitayaphan S; Louisirirotchanakul S; Sutthent R; Brown AE; Birx DL; Polonis VR
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):856-62. PubMed ID: 19058580
[TBL] [Abstract][Full Text] [Related]
4. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
5. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
6. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of beta-chemokine levels during anti-HIV therapy.
Aleman S; Pehrson P; Sönnerborg A
Antivir Ther; 1999; 4(2):109-15. PubMed ID: 10682156
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo.
Ferbas J; Giorgi JV; Amini S; Grovit-Ferbas K; Wiley DJ; Detels R; Plaeger S
J Infect Dis; 2000 Oct; 182(4):1247-50. PubMed ID: 10979927
[TBL] [Abstract][Full Text] [Related]
9. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
[TBL] [Abstract][Full Text] [Related]
10. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
[TBL] [Abstract][Full Text] [Related]
11. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
Boulassel MR; Smith GH; Edwardes MD; Young M; Klein M; Gilmore N; Macleod J; Leblanc R; René P; Allan J; Lalonde RG; Routy JP
HIV Med; 2005 Jul; 6(4):268-77. PubMed ID: 16011532
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2004 Dec; 28(6):197-204. PubMed ID: 15566948
[TBL] [Abstract][Full Text] [Related]
14. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA
J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136
[TBL] [Abstract][Full Text] [Related]
16. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
Shao W; Tang J; Song W; Wang C; Li Y; Wilson CM; Kaslow RA
Genes Immun; 2007 Apr; 8(3):224-31. PubMed ID: 17330138
[TBL] [Abstract][Full Text] [Related]
17. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM
J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Carter LM; Peters BS; Ellis BA; Wolstencroft RA
J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.
Lane BR; Markovitz DM; Woodford NL; Rochford R; Strieter RM; Coffey MJ
J Immunol; 1999 Oct; 163(7):3653-61. PubMed ID: 10490959
[TBL] [Abstract][Full Text] [Related]
20. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
